Accessory toxin-mediated evasion of innate immunity during V. cholerae infection
霍乱弧菌感染期间辅助毒素介导的先天免疫逃避
基本信息
- 批准号:8063715
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptive TransferAnimal ModelAntibodiesBacteriaCell physiologyCellsCholeraCholera ToxinComplementCytoprotectionDataDefectDisabled PersonsDiseaseEpidemicEpidemiologyExcretory functionFibrinogenFrequenciesGeneticGrantGut associated lymphoid tissueHemolysinHost DefenseImmuneImmune responseImmune systemImmunityIndividualInfectionInfectious AgentIntestinesMediatingMesenteryMusNatural ImmunityNeutrophil InfiltrationPathogenesisPatternPersonsRecruitment ActivityResearch DesignRoleSeveritiesSmall IntestinesStructure of aggregated lymphoid follicle of small intestineTimeToxinVibrioVibrio choleraeVibrio cholerae O1Virulencecell typedefined contributiondisease transmissionhemagglutinin-proteaseimmune clearancein vivoinnate immune functionlymph nodesmast cellmutantneutrophilpandemic diseasepublic health relevanceresearch studytransmission process
项目摘要
DESCRIPTION (provided by applicant): Vibrio cholerae O1 is the causative agent of pandemic cholera, a severe diarrheal disease still prevalent worldwide. The major etiologic agent of the Seventh Cholera Pandemic that began in 1961 and continues today is the cholera toxin producing El Tor O1 strains. These strains were first thought to have low virulence potential as they cause disease of less severity than "classical" strain responsible for earlier pandemics. However, the lowered virulence of El Tor strains is believed to have contributed to their pandemic spread since a majority of infected persons do not become ill but do become colonized and excrete the infectious organisms. Indeed, one factor thought to contribute to the emergence of El Tor strains is their ability to persist an average of 5 days in asymptomatic carriers compared to only 1.5 days for classical strains. Thus, El Tor strains have genetic factor(s) absent in classical strains that contribute to prolonged colonization. These genetic factors had not been previously identified. Using a new animal model of cholera amenable to studies of the host immune response, we have demonstrated that accessory toxins hemolysin and RTX are key factors in establishment of prolonged V. cholerae colonization of the crypts of the small intestine. This grant will continue examining the connection between hemolysin, RTX and innate immunity using coinfection studies to determine if colonization defects can be extracellulary complemented. This study will also investigate the cell types recruited to the gut associated lymphoid tissue during early V. cholerae infection. Finally, this project will specifically determine whether neutrophils and mast cells are key components of the innate immune response to V. cholerae and whether these cells are disabled by hemolysin and RTX toxin both in vivo. PUBLIC HEALTH RELEVANCE: Vibrio cholerae O1 is the causative agent of pandemic cholera, a severe diarrheal disease still prevalent worldwide. The epidemiology of modern cholera is distinct from the Classical disease as epidemics are caused by lower virulence strains that induce a high frequency of mild or asymptomatic infections. This prolonged period of vibrio excretion likely contributes to transmission of disease. Using a new animal model of cholera, accessory toxins hemolysin and RTX are shown to be key factors in prolonging intestinal colonization by V. cholerae. This project will investigate key components of the immune response to V. cholerae and identify is accessory toxins are associated with disabling innate immunity.
描述(申请人提供):O1霍乱弧菌是霍乱大流行的病原体,霍乱是一种严重的腹泻疾病,目前仍在世界范围内流行。从1961年开始并持续到今天的第七次霍乱大流行的主要病原体是产生El Tor O1菌株的霍乱毒素。这些菌株最初被认为具有较低的毒力潜力,因为它们引起的疾病没有导致早期大流行的“经典”菌株那么严重。然而,El Tor菌株的毒力降低被认为是导致其大流行传播的原因,因为大多数感染者并没有生病,而是被殖民并排泄了传染病的有机体。事实上,人们认为导致El Tor菌株出现的一个因素是它们在无症状携带者中平均持续5天的能力,而传统菌株只有1.5天。因此,El Tor菌株具有经典菌株所不存在的导致长期定植的遗传因素(S)。这些遗传因素此前并未被发现。利用一种新的霍乱动物模型,我们证明了副毒素溶血素和RTX是霍乱弧菌在小肠隐窝长期定植的关键因素。这笔赠款将继续通过联合感染研究来检查溶血素、RTX和先天免疫之间的联系,以确定是否可以在细胞外补充定植缺陷。这项研究还将调查在霍乱弧菌感染早期招募到肠道相关淋巴组织的细胞类型。最后,该项目将专门确定中性粒细胞和肥大细胞是否是霍乱弧菌先天免疫反应的关键成分,以及这些细胞是否在体内都被溶血素和RTX毒素所禁用。公共卫生相关性:O1霍乱弧菌是霍乱大流行的病原体,霍乱是一种严重的腹泻疾病,目前仍在全世界流行。现代霍乱的流行病学与经典疾病不同,因为流行是由毒力较低的菌株引起的,这些菌株会导致高频率的轻度或无症状感染。这种长时间的弧菌排泄可能会导致疾病的传播。在一种新的霍乱动物模型上,副毒素溶血素和RTX被证明是延长霍乱弧菌肠道定植的关键因素。该项目将研究霍乱弧菌免疫反应的关键成分,并确定副毒素与丧失天然免疫能力有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karla J F Satchell其他文献
Karla J F Satchell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karla J F Satchell', 18)}}的其他基金
Lakeside Conference on Protein Toxins and Effectors 2021
2021 年湖畔蛋白质毒素和效应物会议
- 批准号:
10318832 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Structural Genomics Centers for Infectious Diseases - SARS-CoV-2 Research Activities
传染病结构基因组学中心 - SARS-CoV-2 研究活动
- 批准号:
10439426 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 10万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




